TrademarkDir
EVOLVE
LIVE

Serial Number

98439946

Owner

Mallinckrodt Pharmaceuticals Ireland Limited

Attorney

Camille M. Miller

First Use Date

Apr 16, 2025

Filing Date

Mar 8, 2024

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

EVOLVE Trademark

Serial Number: 98439946 • Registration: 8244223

EVOLVE is a trademark filed by Mallinckrodt Pharmaceuticals Ireland Limited on March 8, 2024. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Mallinckrodt Pharmaceuticals Ireland Limited (7 trademarks)

College Business & Technology Park
Blanchardstown, Dublin 15 D15 TX2V , IE

Entity Type: 77

Trademark Details

Filing Date

March 8, 2024

Registration Date

May 5, 2026

First Use Anywhere

April 16, 2025

First Use in Commerce

April 16, 2025

Published for Opposition

December 10, 2024

Goods & Services

Apparatus and instruments for use in connection with the administration of gases to patients for medical and therapeutic purposes, namely, medical and therapeutic gas delivery systems comprised primarily of gas cylinders, valves, regulators, flow meters, delivery hoses and apparatus and instruments for setting, measuring and regulating the mixture of medical and therapeutic gases delivered to patients

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 5, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
May 5, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 16, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 16, 2026 CNPR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 13, 2026 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 13, 2026 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 13, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 13, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 13, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 13, 2026 COAR
ASSIGNED TO EXAMINER
Feb 26, 2026 DOCK
STATEMENT OF USE PROCESSING COMPLETE
Feb 17, 2026 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 16, 2026 AITU
USE AMENDMENT FILED
Aug 11, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Aug 11, 2025 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 1, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jul 31, 2025 EX1G
SOU EXTENSION 1 FILED
Jul 31, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 31, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 4, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 10, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 10, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 4, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 13, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 13, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 13, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 13, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 13, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 16, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 15, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 15, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 26, 2024 GNRN
NON-FINAL ACTION E-MAILED
Sep 26, 2024 GNRT
NON-FINAL ACTION WRITTEN
Sep 26, 2024 CNRT
ASSIGNED TO EXAMINER
Sep 20, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 23, 2024 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 23, 2024 NWOS
NEW APPLICATION ENTERED
Mar 8, 2024 NWAP

Related Trademarks

More from this Owner

KEENOVA CARES logo

KEENOVA CARES

K logo

K

KEENOVA logo

KEENOVA

KEENOVA CARES COMPASSION. ACCESS. REIMBURSEMENT. EMPOWERMENT. SUPPORT. logo

KEENOVA CARES COMPASSION. ACCESS. REIMBURSEMENT. EMPOWERMENT. SUPPORT.

KEENOVA CARES

KEENOVA CARES

KEENOVA THERAPEUTICS logo

KEENOVA THERAPEUTICS